MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/jnnp-2020-323960

Медицинская библиотека · Journal of neurology, neurosurgery, and psychiatry · 2020

Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome.

Yamagishi Yuko, Kuwahara Motoi, Suzuki Hidekazu, Sonoo Masahiro, Kuwabara Satoshi, Yokota Takanori, Nomura Kyoichi, Chiba Atsuro, Kaji Ryuji, Kanda Takashi, Kaida Ken-Ichi, Mutoh Tatsuro, Yamasaki Ryo, Takashima Hiroshi, Matsui Makoto, Nishiyama Kazutoshi, Sobue Gen, Kusunoki Susumu

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

Approximately 15%-20% of patients with Guillain-Barré syndrome (GBS) are unable to walk independently at 6 months from the onset of neurological symptom. The modified Erasmus GBS outcome score (mEGOS) has been reported as a prognostic tool.Herein we investigated the association between a poor outcome, inability to walk independently at 6 months and presence of antiganglioside antibodies.

METHODS

The clinical and serological data of 177 patients with GBS were retrospectively collected in Japan to assess the associations between a poor outcome and serum IgG antibodies against each ganglioside (GM1, GD1a, GalNAc-GD1a, GQ1b and GT1a). In addition, we investigated whether the combination of mEGOS and serum IgG antibodies against gangliosides is useful in predicting a poor outcome.

RESULTS

The patients with IgG anti-GD1a antibodies more frequently showed poor outcomes than those without these antibodies (9 (36%) of 25 vs 8 (6%) of 127 patients, p<0.001). Particularly, 80% showed a poor outcome when they had both serum IgG anti-GD1a antibody and a high mEGOS of ≥10 on day 7 of admission.

CONCLUSIONS

The combination of serum IgG anti-GD1a antibodies and a high mEGOS could help in making a more accurate prognosis of patients than mEGOS alone, especially for predicting poor outcomes.

Для цитирования: Yamagishi Yuko, Kuwahara Motoi, Suzuki Hidekazu, Sonoo Masahiro, Kuwabara Satoshi, Yokota Takanori, Nomura Kyoichi, Chiba Atsuro, Kaji Ryuji, Kanda Takashi, Kaida Ken-Ichi, Mutoh Tatsuro, Yamasaki Ryo, Takashima Hiroshi, Matsui Makoto, Nishiyama Kazutoshi, Sobue Gen, Kusunoki Susumu. Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome.. Journal of neurology, neurosurgery, and psychiatry. 2020. DOI: 10.1136/jnnp-2020-323960.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.